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In their recent article, Gosavi et al. (2013) 
presented the results of a crystallographic 
analy  sis of the binding of tetrabromo­
bisphenol A (TBBPA) and 3­hydroxy­
2,2´,4,4´­tetrabromo diphenyl  ether 
(3­OH­BDE­47) to estrogen sulfotransferase 
(SULT1E1). The authors demon  strated that 
the tested mole  cules fit into the same bind­
ing pocket as estradiol. However, although 
the study’s methodology and interpreta­
tion of the crystallographic analysis provide 
insight into how binding might occur in 
isolated and in vitro systems, they did not 
provide evidence that the tested mole  cules 
would initiate any biological activity with 
the rele  vant estrogen receptors (ERs) or pro­
teins in a human body. For example, the 
ability of TBBPA to inter  act with the ER 
and estrogen­related receptors has been 
evaluated in recombi  nant yeast strains, 
mammalian cell–based assays, and tests 
developed by the Organisation for Economic 
Co­operation and Development (Lee et al. 
2012; Nakagawa et al. 2007; Ogunbayo 
et al. 2007, 2008; Reistad et al. 2005, 2007; 
Strack et al. 2007). Those studies found that 
TBBPA either did not interact with ERs or 
that it acted as a weak ER agonist/antagonist 
with a potency orders of magnitude below 
that of natural ER ligands. In addition, the 
data presented by Gosavi et al. (2013) did 
not include the use of controls to validate 
the methods. The use of both positive con­
trols (such as diethylstilbestrol and ethinyl 
estradiol) and a negative control (such as 
testosterone) would provide validation of 
the analysis and allow for the quantifica­
tion and comparison of the two test sub­
stances in relation to the binding potentials 
of the controls.
The authors also speculated about the 
possible additivity of the various brominated 
flame retardants and their metabolites and 
suggested that low­dose exposure to mul­
tiple low­affinity binding compounds may 
result in endocrine disruption. However, 
none of the data presented directly addressed 
this point.
It is highly complex, not well under­
stood, and speculative to extrapolate data 
on inhibition of enzymes such as SULT1E1 
in in vitro assay systems to endocrine­system 
modulation of selective gene expression, 
receptor binding, and activation and the 
production of adverse effects that would 
characterize endocrine disruption in vivo by 
additivity of different chemicals competing 
on the same receptors. Only through a more 
complete understanding of target tissue 
dosimetry, potency of inter  action of the 
chemical of interest with the macro  molecule 
of interest (e.g., SULT1E1), and subsequent 
events can one address the likelihood of 
in vivo additivity.
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Previous studies have addressed the 
biological effects of brominated flame retar­
dants (Birnbaum and Staskal 2004; Koike 
et al. 2013; Mariussen and Fonnum 2003; 
Ogunbayo et al. 2008), including a 2­year 
bioassay study performed by the National 
Toxicology Program (NTP), which demon­
strated  that  tetra bromo bisphenol  A  (TBBPA) 
can induce aggressive uterine tumors in rats 
(NTP 2013). As pointed out by Osimitz 
et al., TBBPA has been shown to bind poorly 
to the estrogen receptor, providing the impe­
tus to study other pathways such as disrup­
tion of steroid transport and metabolism. 
Other groups have demonstrated the ability 
of TBBPA and flame retardant metabolites to 
inhibit estrogen sulfo  transferase (SULT1E1), 
with IC50 (median inhibitory concentration) 
values near the Km for estradiol (Hamers 
et al. 2008; Kester et al. 2002; Zhang et al. 
1998). Our work (Gosavi et al. 2013) was 
focused solely on understanding the struc­
tural mechanism by which these compounds 
bind to and inhibit SULT1E1’s ability to 
metabolize estradiol. The results of our work 
demonstrate that TBBPA and the 3­OH 
metabolite of BDE­47, although structur­
ally different, bind in a simi  lar manner at 
the estradiol binding site. This work suggests 
that these compounds could have an additive 
effect on the inhibition of this enzyme. We 
wholeheartedly agree with Osimitz et al. that 
the results of our work warrant future studies 
addressing the potential additive effect of 
these compounds on steroid metabolism in 
target tissues.
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